FY2025 EPS Estimates for Integer Lowered by Zacks Research

Integer Holdings Co. (NYSE:ITGR - Free Report) - Stock analysts at Zacks Research dropped their FY2025 EPS estimates for shares of Integer in a research note issued on Tuesday, October 22nd. Zacks Research analyst D. Dey now forecasts that the medical equipment provider will post earnings per share of $6.03 for the year, down from their prior estimate of $6.04. The consensus estimate for Integer's current full-year earnings is $5.30 per share. Zacks Research also issued estimates for Integer's Q1 2026 earnings at $1.64 EPS, Q3 2026 earnings at $1.66 EPS and FY2026 earnings at $6.68 EPS.

Several other research firms have also recently commented on ITGR. Citigroup boosted their target price on Integer from $124.00 to $130.00 and gave the stock a "neutral" rating in a research note on Tuesday, October 1st. Bank of America upped their target price on shares of Integer from $135.00 to $145.00 and gave the stock a "buy" rating in a research note on Tuesday, October 1st. Oppenheimer started coverage on shares of Integer in a report on Tuesday, July 16th. They set an "outperform" rating and a $135.00 price target for the company. KeyCorp raised their price objective on shares of Integer from $139.00 to $144.00 and gave the company an "overweight" rating in a report on Tuesday, October 15th. Finally, Truist Financial boosted their target price on shares of Integer from $145.00 to $150.00 and gave the stock a "buy" rating in a research note on Monday, October 14th. One analyst has rated the stock with a hold rating and six have assigned a buy rating to the company's stock. According to MarketBeat, Integer has a consensus rating of "Moderate Buy" and an average target price of $140.14.

Integer Trading Up 0.8 %

Shares of ITGR stock traded up $0.98 on Wednesday, hitting $126.53. The stock had a trading volume of 346,838 shares, compared to its average volume of 311,955. The company's 50 day moving average price is $127.19 and its 200-day moving average price is $120.82. The company has a debt-to-equity ratio of 0.73, a current ratio of 3.29 and a quick ratio of 1.96. Integer has a 1 year low of $69.40 and a 1 year high of $133.53. The firm has a market capitalization of $4.24 billion, a P/E ratio of 43.45, a P/E/G ratio of 1.86 and a beta of 1.08.

Integer (NYSE:ITGR - Get Free Report) last released its quarterly earnings data on Thursday, July 25th. The medical equipment provider reported $1.30 EPS for the quarter, beating analysts' consensus estimates of $1.24 by $0.06. The firm had revenue of $436.20 million for the quarter, compared to analysts' expectations of $437.00 million. Integer had a return on equity of 11.48% and a net margin of 6.31%. The firm's quarterly revenue was up 9.0% on a year-over-year basis. During the same period in the prior year, the firm posted $1.14 earnings per share.

Institutional Investors Weigh In On Integer

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. GSA Capital Partners LLP purchased a new stake in Integer during the first quarter worth about $786,000. Blue Trust Inc. grew its holdings in shares of Integer by 460.4% in the 2nd quarter. Blue Trust Inc. now owns 5,643 shares of the medical equipment provider's stock worth $658,000 after acquiring an additional 4,636 shares during the period. UniSuper Management Pty Ltd purchased a new position in shares of Integer in the first quarter valued at $976,000. Moloney Securities Asset Management LLC purchased a new position in Integer during the 1st quarter valued at about $927,000. Finally, Earnest Partners LLC raised its position in Integer by 3.2% during the second quarter. Earnest Partners LLC now owns 1,208,319 shares of the medical equipment provider's stock worth $139,911,000 after acquiring an additional 37,340 shares during the last quarter. Institutional investors and hedge funds own 99.29% of the company's stock.

Insider Transactions at Integer

In related news, Director Jean M. Hobby sold 11,960 shares of the firm's stock in a transaction dated Wednesday, July 31st. The shares were sold at an average price of $119.66, for a total value of $1,431,133.60. Following the completion of the sale, the director now owns 2,280 shares in the company, valued at $272,824.80. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 2.00% of the company's stock.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.